Fanzor

Due to its eukaryotic origin, the OMEGA Fanzor system may have some advantages over the better studied CRISPR/Cas gene editor in terms of human genome editing applications.^[1] In a CRISPR/Cas9 system, Cas9 proteins are guided by the guide RNA (gRNA) and protospacer adjacent motif (PAM) for DNA cleavage. Interestingly, Fanzor genes in the soil fungus S. punctatus ^[1][5] also contain non-coding sequences called ωRNA. Similar to CRISPR/Cas9, Fanzor protein is shown to cleave DNA in test tubes under the guidance of ωRNA and target-adjacent motif (TAM).^[1]

As shown in the schematic, Cas9 DNA cleavage is instructed by the gRNA and the PAM sequence "NGG"^[7] on the target DNA, where N can be any of the four DNA components (A, G, C or T). Similarly, Fanzor DNA cleavage is instructed by the ωRNA and the TAM sequence "CATA" on the target DNA1. Not an accurate representation of size and structure of the RNAs and proteins.

In human cells, the Fanzor protein of Spizellomyces punctatus was successfully tested and shown to cleave DNA effectively.^[1] However, its efficiency is lower compared to the closely related CRISPR/Cas12a system.^[1] By modifying and tweaking the ωRNA and the amino acid sequence, a second version of the S. punctatus Fanzor protein with improved cleavage efficiency - comparable to that of the CRISPR/Cas12a system - was engineered.^[1] This shows that, with better modifications and more research, OMEGA Fanzor has the potential to match the CRISPR system in human genome editing in the future.

Studies conclude that Fanzor has great potential for efficient human genome editing^[1][6] with a higher chance of not getting attacked by the immune system.^[6] For example, Fanzor could be used in personalized cancer treatments where the patient's own T-cells - important cells of the immune system that recognize and fight foreign pathogens - are edited in order to recognize and destroy cancer cells.^[2][8] In the field of regenerative medicine, it offers hope for an application in stem cell therapy to treat many disease of genetic origin like type 1 diabetes or neurodegenerative diseases.^[2]

Furthermore, Fanzor could potentially be used for genome editing in eggs and sperm^[2] for disease prevention and infertility treatment. However, the intervention in such cells' DNA comes with risks and requires strict ethical guidelines.^[9]

One major advantage of Fanzor in comparison to the CRISPR/Cas9 system is its small size. Therefore, it can be delivered with viral vectors, which are modified dead bodies of viruses engineered to safely deliver genetic material, such as adenoviruses.^[4] Adenoviruses are commonly used in medical applications like gene deliveries or vaccines^[10] that do not elicit immune responses within the human body.^[4]

However, researchers caution that further research is necessary to improve the editing efficiency^[1][6] and precision.^[1]

Next to the application in human cells, Fanzor is a prospective tool for specific genome editing in plants, because of the aforementioned advantages of the protein being a small size.^[2] Thereby, the nutrient content, the resistance to diseases and the affordability of crops could be improved.^[11] Moreover, in regard to the current and arising challenges caused by climate change, crops could be adjusted to better endure stress factors such as drought, salinity and increasing temperatures.^[12]